We've seen self-assembling chips, self-healing panels, and even regenerative houses hit the drawing board before, but California-based Oculus has created a liquid that can reportedly quicken the healing process when recovering from wounds. The firm's Dermacyn topical wound care is an "oxychlorine formulation" using the company's own Microcyn concoction, which is made by "taking purified water and passing it through a semi-permeable sodium chloride membrane to produce the oxychlorine ions," and essentially contains "electrically charged molecules which pierce the cell walls of free-living microbes." The formula is reportedly successful in killing off virii, bacteria, and fungi, and currently, the company is enrolling patients in a Phase II trial to evaluate its effectiveness in treating diabetic foot infections. The company is hoping to start said trial in Q3 of this year, and if all goes well, wants to execute a pair of larger Phase III trials shortly thereafter.

[Via BBC]